Literature DB >> 8641984

Detection of low-level expression of P-glycoprotein in ACHN renal adenocarcinoma cells.

S Kawamoto1, T Deguchi, S Nezasa, S Yamada, M Okano, Y Kawada.   

Abstract

A highly sensitive reverse transcriptase-polymerase chain reaction (RT-PCR) assay and a flow cytometric assay were used to examine ACHN cells for the expression of P-glycoprotein. The expression of P-glycoprotein was detected at the RNA and protein levels in ACHN cells by RT-PCR and flow cytometry, respectively. However, it was below the limit of detection by immunoblotting. The intracellular accumulation of adriamycin in ACHN cells was enhanced by verapamil, cyclosporin A and medroxyprogesterone acetate. Therefore, this study has demonstrated that low-level expression of P-glycoprotein detectable only by RT-PCR and flow cytometry plays a significant role in reducing the intracellular concentration of antitumor agents and thus contributes to the multidrug-resistant phenotype of ACHN cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641984      PMCID: PMC5921118          DOI: 10.1111/j.1349-7006.1996.tb00248.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells.

Authors:  A Krishan; A Sauerteig; J H Stein
Journal:  Cytometry       Date:  1991

2.  Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns.

Authors:  S Nakajima-Iijima; H Hamada; P Reddy; T Kakunaga
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

3.  Flow cytometric double labeling technique for screening of multidrug resistance.

Authors:  E E Gheuens; D R van Bockstaele; M van der Keur; H J Tanke; A T van Oosterom; E A De Bruijn
Journal:  Cytometry       Date:  1991

4.  Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.

Authors:  E C Borden; T F Hogan; J G Voelkel
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

5.  Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas.

Authors:  K Nishiyama; T Shirahama; A Yoshimura; T Sumizawa; T Furukawa; M Ichikawa-Haraguchi; S Akiyama; Y Ohi
Journal:  Cancer       Date:  1993-06-01       Impact factor: 6.860

6.  [Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran coated charcoal (DCC) assay and immunocytochemical assay].

Authors:  T Ozaki
Journal:  Gan To Kagaku Ryoho       Date:  1992-03

7.  Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro.

Authors:  L Kangas; M Grönroos; A L Nieminen
Journal:  Med Biol       Date:  1984

8.  Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.

Authors:  L M Slater; P Sweet; M Stupecky; S Gupta
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

9.  Verapamil and cyclosporin A sensitize human kidney tumor cells to vincristine in absence of membrane P-glycoprotein and without apparent changes in the cytoplasmic free Ca2+ concentration.

Authors:  P Nygren; R Larsson
Journal:  Biosci Rep       Date:  1990-04       Impact factor: 3.840

10.  Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.

Authors:  G H Mickisch; K Roehrich; J Koessig; S Forster; R K Tschada; P M Alken
Journal:  J Urol       Date:  1990-09       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.